GLENMARK

Glenmark Pharmaceuticals Ltd., a prominent player in the Pharmaceuticals and Biotechnology sector, has emerged as one of the most active equities by value. As of July 10, 2025, the company’s stock, trading under the symbol GLENMARK, recorded a total traded volume of 1,740,600 shares, with a total traded value of approximately Rs 32.44 crore. The stock opened at Rs 1,821.9 and reached a day’s high of Rs 1,888.0, marking a 3.58% increase from the previous close of Rs 1,818.8. Notably, Glenmark Pharmaceuticals hit a new 52-week and all-time high of Rs 1,884 today. The stock has shown resilience, gaining 3.69% on the day, outperforming its sector, which saw a decline of 0.77%. Additionally, Glenmark is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend reversal after two consecutive days of decline. The delivery volume on July 9 was 744,000 shares, reflecting a significant increase of 71.77% compared to the 5-day average. With a market capitalization of Rs 53,220.25 crore, Glenmark Pharmaceuticals continues to demonstrate strong liquidity, suitable for trades up to Rs 3.77 crore. Overall, Glenmark's performance today highlights its active presence in the market.